The representation of Black and Asian adults is on the rise in atopic dermatitis clinical trials, according to a study. As ...

Dermatology providers reported strong impacts on the work and home life of patients with moderate to severe chronic hand eczema, a manifestation of atopic dermatitis.

Raj Chovatiya, MD, PhD, MSCI, highlights the long-term effectiveness of lebrikizumab across diverse patients, including those ...

Background: The relationship between atopic dermatitis (AD) and lymphoma risk remains debate. This study systematically evaluates lymphoma risk in AD patients compared to non-AD individuals. Methods: ...

WASHINGTON ‒ Adam Sanchez remembers tears streaming down a student’s face as his high school class left the lower level of the National Museum of African American History and Culture a few ...

placebo (95%CI：9.27~74.62). In the higher dose group, 41.7% of patients (5/12) achieved a validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD™) score of 0 (clear) or 1 (almost ...

Gertrude Theresa Hodges, the first African American Johns Hopkins School of Nursing graduate, died of stroke complications March 28 at her East Baltimore home. She was 88. Mrs. Hodges also headed ...

Its lead product candidate, Zabalafin Hydrogel, is being developed as a topical treatment for atopic dermatitis (AD), the most common form of eczema. Zabalafin Hydrogel has demonstrated strong ...

In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.

More Americans than not hold either uncertain or negative views of President Donald Trump's moves to upend traditional U.S. foreign policy, according to a new poll released Tuesday. The survey was ...

Children with early-onset atopic dermatitis have a higher risk of developing pediatric uveitis compared to matched controls. The study found increased uveitis risk in patients untreated with dupilumab ...

Upadacitinib outperformed dupilumab for clinically meaningful pruritus improvement among patients with moderate to severe atopic dermatitis as early as day ... independently and is not endorsed by the ...